General Rheumatology

Obesity is common in inflammatory arthritis, with an estimated 60-70% of people with rheumatoid arthritis and 70-80% of people with psoriatic arthritis also living with overweight or obesity. But does obesity affect disease activity and outcomes in inflammatory arthritis?

Despite our increased understanding of lupus immunology including treatment options, many of our patients with SLE continue to experience significant functional impairment and work disability. Several abstracts from ACR 2026 highlight the burden of work disability, the factors associated with

Obesity is associated with poorer physical function and treatment response in rheumatoid arthritis (RA). The ACR guideline on exercise, rehabilitation and diet supports discussing healthy body weight as part of wider RA care. But what happens to patients’ symptoms when they lose weight after

One of the most common questions I receive in my vasculitis clinic is one of the most difficult to answer: “When can we stop rituximab?” While we know everyone needs therapy for at least one year and have reasonably good data for 18 months, whether folks should continue after that remains an

Consider holding methotrexate for two weeks after each recombinant zoster vaccine dose when disease is stable, and give the vaccine before rituximab when timing allows. Those are the messages from a pair of abstracts presented by Ana Cristina Medeiros-Ribeiro of the HC-FMUSP group